Max Healthcare Institute Limited has announced that a meeting of its Board of Directors is scheduled for May 21, 2026. During this session, the Board will review and approve the standalone and consolidated financial results for the quarter and financial year ended March 31, 2026. Additionally, the company will discuss and potentially recommend a final dividend for shareholders regarding the 2025-2026 fiscal year.
Board Meeting Agenda
The upcoming board meeting, set for May 21, 2026, will serve as a pivotal moment for the company’s fiscal reporting. The primary focus of the meeting is the approval of the financial results for both the final quarter (Jan-Mar 2026) and the full financial year concluded on March 31, 2026.
Dividend Consideration
In addition to financial reporting, the Board is expected to deliberate on the declaration of a final dividend for the equity shares of the company for the financial year ending March 31, 2026. This decision will reflect the company’s performance and capital allocation strategy for the past year.
Trading Window Restrictions
To ensure regulatory compliance and maintain market integrity, the company has implemented a closure of its trading window. This restriction applies to all designated persons and their immediate relatives. The trading window will remain closed until 48 hours following the official declaration and public release of the financial results.
Source: BSE
